Neupogen Amgen 30, Injektionslösung

7680510351439 CH-51035 Injektionslösung
Neupogen Amgen 30, Injektionslösung
Neupogen Amgen 30, Injektionslösung
Neupogen Amgen 30, Injektionslösung
1 / 3
google

Article details

Package size
5 x 1 mL
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/12/2022
Summary of Product Characteristics
Français
16/12/2022
Summary of Product Characteristics
Italien
16/12/2022

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
31.9 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
50.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 388.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1994

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
51035
Drug name
Neupogen Amgen, Injektionslösung
Galenic form
LSINJ
ATC Code
L03AA02
Authorization status
Z
Dispensing category
A
First authorization
11/10/1991
Authorization expiration date
31/12/9999
IT Number
06.07.3.
Domain
Human medicine
Field of application
Neutropenie

Package details

Description (FR)
NEUPOGEN Amgen 30 mio U/ml flacon 5 pce
Description (DE)
NEUPOGEN Amgen 30 Mio E/ml Durchstechf 5 Stk
Market launch
11/10/1991
Narcotic (BTM)
No

Other package sizes (5)

NEUPOGEN AMGEN sol 48 mio U vial 5 pce
5 x 1.6 mL DUR
GTIN: 7680510351514
Not in V1
None
None None
GTIN: None
Not in V1
NEUPOGEN Amgen 30 mio U/0.5ml ser pré 5 pce
5 x 0.5 mL SPRI
GTIN: 7680510351866
View
None
None None
GTIN: None
Not in V1
NEUPOGEN Amgen 48 mio U/0.5ml ser pré 5 pce
5 x 0.5 mL SPRI
GTIN: 7680510352085
View